There is good news ahead for herpes patients, who usually suffer through a week of treatment before their pain and symptoms are resolved.
The FDA has recently approved Famvir as a one-day treatment option for patients with genital herpes, the first of its kind. Used properly, under the new FDA dosing regimen guidelines, Famvir can be used to prevent herpes outbreaks or curtail them as they occur.
This is a huge step in treatment for a virus that affects 45 million people in the U.S. and whose...
Read moreI recently logged on to a chat of a bunch of young adults with herpes. Not surprisingly, many of them felt ashamed, frustrated and... Read more »
The American College of Rheumatology recently issued new guidelines for rheumatologists to use in their patient treatment decisions about... Read more »
Long-term treatment of genital herpes with the drug acyclovir does not reduce the incidence of new HIV infections. This unwelcome and... Read more »
Ok. So you've tried the antivirals to control your herpes and are looking for something else. Or, you want a natural approach to managing... Read more »
I'm always amazed at the amount of misinformation, or lack of information, that people have about Herpes. Often when I tell a new partner... Read more »
Researchers at the University of Florida are researching a treatment that may help prevent the recurrence of herpes. The approach uses an RNA enzyme... Read more »
Researchers have identified a potential new target in the ongoing quest for a treatment, and possibly a cure, for the herpes virus. Read more »
(Ivanhoe Newswire) -- New research reveals a surprising interaction between a drug used for herpes and HIV. The research shows that drug, acyclovir... Read more »
1. Practice good hygiene. Keep your body clean, wash your hands frequently and try to avoid touching the sores. 2. Take salt baths. This method can... Read more »
On June 9, the Food and Drug Administration approved the first effective vaccine against Human Papillomavirus, a sexually transmitted infection that... Read more »